Logo image of BHC

BAUSCH HEALTH COS INC (BHC) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:BHC - CA0717341071 - Common Stock

5.8 USD
-0.11 (-1.86%)
Last: 1/26/2026, 8:04:00 PM
5.8 USD
0 (0%)
After Hours: 1/26/2026, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, BHC scores 4 out of 10 in our fundamental rating. BHC was compared to 190 industry peers in the Pharmaceuticals industry. While BHC is still in line with the averages on profitability rating, there are concerns on its financial health. BHC has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • BHC had positive earnings in the past year.
  • BHC had a positive operating cash flow in the past year.
  • BHC had negative earnings in each of the past 5 years.
  • Of the past 5 years BHC 4 years had a positive operating cash flow.
BHC Yearly Net Income VS EBIT VS OCF VS FCFBHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 1.35%, BHC is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
  • BHC has a Return On Invested Capital of 7.44%. This is amongst the best in the industry. BHC outperforms 84.74% of its industry peers.
  • BHC had an Average Return On Invested Capital over the past 3 years of 5.98%. This is significantly below the industry average of 12.83%.
  • The 3 year average ROIC (5.98%) for BHC is below the current ROIC(7.44%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.35%
ROE N/A
ROIC 7.44%
ROA(3y)-1.07%
ROA(5y)-1.65%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.98%
ROIC(5y)5.41%
BHC Yearly ROA, ROE, ROICBHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800

1.3 Margins

  • BHC has a Profit Margin of 3.61%. This is in the better half of the industry: BHC outperforms 80.00% of its industry peers.
  • Looking at the Operating Margin, with a value of 20.68%, BHC belongs to the top of the industry, outperforming 87.37% of the companies in the same industry.
  • BHC's Operating Margin has improved in the last couple of years.
  • With a decent Gross Margin value of 70.67%, BHC is doing good in the industry, outperforming 77.89% of the companies in the same industry.
  • BHC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.68%
PM (TTM) 3.61%
GM 70.67%
OM growth 3Y1.02%
OM growth 5Y4.43%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.24%
GM growth 5Y-0.44%
BHC Yearly Profit, Operating, Gross MarginsBHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BHC is creating some value.
  • The number of shares outstanding for BHC has been increased compared to 1 year ago.
  • BHC has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for BHC has been reduced compared to a year ago.
BHC Yearly Shares OutstandingBHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
BHC Yearly Total Debt VS Total AssetsBHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

  • BHC has an Altman-Z score of 0.24. This is a bad value and indicates that BHC is not financially healthy and even has some risk of bankruptcy.
  • BHC has a Altman-Z score (0.24) which is in line with its industry peers.
  • The Debt to FCF ratio of BHC is 19.41, which is on the high side as it means it would take BHC, 19.41 years of fcf income to pay off all of its debts.
  • BHC has a Debt to FCF ratio of 19.41. This is in the better half of the industry: BHC outperforms 76.32% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 19.41
Altman-Z 0.24
ROIC/WACC1.09
WACC6.81%
BHC Yearly LT Debt VS Equity VS FCFBHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

2.3 Liquidity

  • A Current Ratio of 1.30 indicates that BHC should not have too much problems paying its short term obligations.
  • BHC has a worse Current ratio (1.30) than 76.84% of its industry peers.
  • A Quick Ratio of 0.97 indicates that BHC may have some problems paying its short term obligations.
  • BHC's Quick ratio of 0.97 is on the low side compared to the rest of the industry. BHC is outperformed by 78.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.97
BHC Yearly Current Assets VS Current LiabilitesBHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 1.33% over the past year.
  • BHC shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.91% yearly.
  • Looking at the last year, BHC shows a small growth in Revenue. The Revenue has grown by 5.86% in the last year.
  • The Revenue has been growing slightly by 2.28% on average over the past years.
EPS 1Y (TTM)1.33%
EPS 3Y-5.37%
EPS 5Y-2.91%
EPS Q2Q%2.65%
Revenue 1Y (TTM)5.86%
Revenue growth 3Y4.5%
Revenue growth 5Y2.28%
Sales Q2Q%6.81%

3.2 Future

  • Based on estimates for the next years, BHC will show a decrease in Earnings Per Share. The EPS will decrease by -3.58% on average per year.
  • Based on estimates for the next years, BHC will show a decrease in Revenue. The Revenue will decrease by -0.40% on average per year.
EPS Next Y5.12%
EPS Next 2Y6.66%
EPS Next 3Y-1.71%
EPS Next 5Y-3.58%
Revenue Next Year6.13%
Revenue Next 2Y5.11%
Revenue Next 3Y3.03%
Revenue Next 5Y-0.4%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BHC Yearly Revenue VS EstimatesBHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
BHC Yearly EPS VS EstimatesBHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

9

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 1.52, the valuation of BHC can be described as very cheap.
  • 98.95% of the companies in the same industry are more expensive than BHC, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of BHC to the average of the S&P500 Index (27.25), we can say BHC is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 1.35, the valuation of BHC can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, BHC is valued cheaply inside the industry as 98.95% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of BHC to the average of the S&P500 Index (25.98), we can say BHC is valued rather cheaply.
Industry RankSector Rank
PE 1.52
Fwd PE 1.35
BHC Price Earnings VS Forward Price EarningsBHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BHC is valued cheaper than 93.68% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BHC indicates a rather cheap valuation: BHC is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 1.98
EV/EBITDA 6.65
BHC Per share dataBHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of BHC may justify a higher PE ratio.
PEG (NY)0.3
PEG (5Y)N/A
EPS Next 2Y6.66%
EPS Next 3Y-1.71%

0

5. Dividend

5.1 Amount

  • BHC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BAUSCH HEALTH COS INC / BHC FAQ

What is the ChartMill fundamental rating of BAUSCH HEALTH COS INC (BHC) stock?

ChartMill assigns a fundamental rating of 4 / 10 to BHC.


Can you provide the valuation status for BAUSCH HEALTH COS INC?

ChartMill assigns a valuation rating of 9 / 10 to BAUSCH HEALTH COS INC (BHC). This can be considered as Undervalued.


Can you provide the profitability details for BAUSCH HEALTH COS INC?

BAUSCH HEALTH COS INC (BHC) has a profitability rating of 6 / 10.


Can you provide the financial health for BHC stock?

The financial health rating of BAUSCH HEALTH COS INC (BHC) is 2 / 10.